Diagnosis and Treatment of Latent Tuberculosis Infection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Seung Heon | - |
dc.date.accessioned | 2021-09-04T17:45:02Z | - |
dc.date.available | 2021-09-04T17:45:02Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015-04 | - |
dc.identifier.issn | 1738-3536 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93986 | - |
dc.description.abstract | A small number of viable tuberculosis bacilli can reside in an individual with latent tuberculosis infection (LTBI) without obvious clinical symptoms or abnormal chest radiographs. Diagnosis and treatment for LTBI are important for tuberculosis (TB) control in public and private health, especially in high-risk populations. The updated 2014 Korean guidelines for TB recommend that tuberculin skin tests, interferon-gamma release assays, or a combination of the two can be used for LTBI diagnosis according to age and immune status of the host as well as TB contact history. The regimens for LTBI treatment include isoniazid, rifampicin, or isoniazid/rifampicin. However, results of drug susceptibility test from the index case must be considered in selecting the appropriate drug for recent contacts. Standardized LTBI diagnosis and treatment based on the new 2014 guidelines will contribute to the effective TB control in Korea as well as to the establishment of updated guidelines. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | TAEHAN KYORHAEK HYOPHOE-KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES | - |
dc.subject | NECROSIS-FACTOR ANTAGONISTS | - |
dc.subject | GAMMA RELEASE ASSAYS | - |
dc.subject | CELL-BASED ASSAY | - |
dc.subject | SKIN-TEST | - |
dc.subject | RISK | - |
dc.title | Diagnosis and Treatment of Latent Tuberculosis Infection | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Seung Heon | - |
dc.identifier.doi | 10.4046/trd.2015.78.2.56 | - |
dc.identifier.scopusid | 2-s2.0-84929396861 | - |
dc.identifier.wosid | 000420537000002 | - |
dc.identifier.bibliographicCitation | TUBERCULOSIS AND RESPIRATORY DISEASES, v.78, no.2, pp.56 - 63 | - |
dc.relation.isPartOf | TUBERCULOSIS AND RESPIRATORY DISEASES | - |
dc.citation.title | TUBERCULOSIS AND RESPIRATORY DISEASES | - |
dc.citation.volume | 78 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 56 | - |
dc.citation.endPage | 63 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART001978562 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordPlus | NECROSIS-FACTOR ANTAGONISTS | - |
dc.subject.keywordPlus | GAMMA RELEASE ASSAYS | - |
dc.subject.keywordPlus | CELL-BASED ASSAY | - |
dc.subject.keywordPlus | SKIN-TEST | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Latent Tuberculosis | - |
dc.subject.keywordAuthor | Tuberculin Test | - |
dc.subject.keywordAuthor | Interferon-Gamma Release Assay | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.